ibe_banner

Ngwaahịa

PMSF Cas: 329-98-6 98.0% ọcha crystalline ntụ ntụ Phenylmethanesulfonyl fluoride (PMSF)

Nkọwa dị mkpirikpi:

Nọmba katalọgụ: XD90250
Cas: 329-98-6
Ụdị molekụla: C7H7FO2S
Ibu Molecular: 174.1927
Nnweta: Dị na ngwaahịa
Ọnụ ahịa:  
Nkwakọ ngwaahịa: 5g USD20
Ngwungwu nnukwu: Rịọ Quote

 

 

 

 

 

 


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nọmba katalọgụ XD90250

Aha ngwaahịa

Phenylmethanesulfonyl fluoride (PMSF)

CAS

329-98-6

Usoro ihe omimi

C7H7FO2S

Ibu molekụla

174.1927
Nkọwa nchekwa Ambient

Koodu tarifu akwadoro

29049900

 

Nkọwapụta ngwaahịa

Nyocha ≥98.0% HPLC
Ọdịdị ọcha crystalline ntụ ntụ

 

PMSF bụ serine/cysteine ​​​​protease inhibitor na-adịghị agbanwe agbanwe nke a na-ejikarị na nkwadebe nke cell lysates.

 

Ọmụmụ in vitro: PMSF (2 mM) na-egbochi mkpokọta inositol phosphate nke carbachol na-akpali naanị 15%-19% na ọnụnọ Li +.Mgbochi nke ntụgharị phosphoinotide site na PMSF bụ n'ihi otu usoro ma ọ bụ karịa na-eso nkwụsị nke phosphoinotides [1].PMSF na-egbochi acylation nke inositol residues nke GPI intermediates n'ime ọbara nke T. brucei.PMSF na-egbochi nhazi glycolipid C mana ọ bụghị imegharị acid fatty na vitro.PMSF na-egbochi mgbakwunye GPI acylation na ethanolamine phosphatase na procyclic trypanosomes, mana ọ bụghị na sel Hela [2].

Na ọmụmụ vivo: PMSF (0.1 mL / 10 g b.wt, ip) mepụtara antinociception, dị ka egosipụtara site na mmụba na-anabata dose na% MPE na nyocha latency ọdụ ọdụ, mana ọ naghị emepụta ihe mgbochi moto na-anabata nke ọma.Ụmụ oke natara intraperitoneal injection nke PMSF gosipụtara mmetụta cannabinoid gụnyere antinociception, hypothermia na immobility na ED50 ụkpụrụ nke 86, 224 na 206 mg / kg, n'otu n'otu.PMSF (30 mg / kg) pretreatment na-eme ka mmetụta nke anandamide na nzaghachi ọdụ ọdụ (antinociception), ọrụ locomotor na mmegharị site na 5-fold, 10-fold and 8-fold, n'otu n'otu [3].

Nnwale anụmanụ: A na-eji ụmụ oke ICR nwoke na-eru 18 ruo 25 g na nyocha.A gbazere PMSF na mmanụ sesame ma nye ya intraperitoneal n'ogo nke 0.1 mL / 10 g b.wt.Na-enye PMSF oge niile nkeji iri tupu anadamide intravenous ma ọ bụ ntụtụ ụgbọ ala.A kpọbatara ụmụ oke n'ọnụ ụlọ nyocha n'otu abalị na-enweghị nkwụsị nke nri ma ọ bụ mmiri.Na-eso anandamide intravenous ma ọ bụ nchịkwa ụgbọ ala, a na-enyocha anụmanụ ọ bụla dị ka ndị a: 5 nkeji maka nzaghachi ọdụ-flick (antinociceptive) nzaghachi na 5 ruo 15 nkeji maka ọrụ mberede (moto);ma ọ bụ nkeji 5 maka okpomoku isi (rectal) na mgbanaka Immobilization (catalepsy) maka nkeji 5 ruo 10.


  • Nke gara aga:
  • Osote:

  • Mechie

    PMSF Cas: 329-98-6 98.0% ọcha crystalline ntụ ntụ Phenylmethanesulfonyl fluoride (PMSF)